Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/119540
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant
Author: Au, E.H.
Chapman, J.R.
Craig, J.C.
Lim, W.H.
Teixeira-Pinto, A.
Ullah, S.
McDonald, S.
Wong, G.
Citation: Journal of the American Society of Nephrology, 2019; 30(3):471-480
Publisher: American Society of Nephrology
Issue Date: 2019
ISSN: 1046-6673
1533-3450
Statement of
Responsibility: 
Eric H. Au, Jeremy R. Chapman, Jonathan C. Craig, Wai H. Lim, Armando Teixeira-Pinto, Shahid Ullah, Stephen McDonald, and Germaine Wong
Abstract: Background: Patients with ESRD have a substantially increased cancer risk, but few studies have examined the patterns of cancer mortality along a patient's journey from dialysis to transplantation. Methods: We identified all Australian patients on dialysis and patients with transplants from 1980 to 2014 from the Australia and New Zealand Dialysis and Transplant Registry. Using standardized mortality ratios (SMRs), we compared cancer mortality among patients on dialysis and patients with transplants versus the general population (overall and by age, sex, year, and site); we also performed a subgroup analysis excluding patients with preexisting cancers. Results: We followed 52,936 patients on dialysis and 16,820 transplant recipients for 170,055 and 128,352 patient-years, respectively. There were 2739 cancer deaths among patients on dialysis and 923 cancer deaths among transplant recipients. Overall, cancer SMRs were 2.6 for patients on dialysis and 2.7 for transplant recipients. For patients on dialysis, SMRs were highest for multiple myeloma (30.5), testicular cancer (17.0), and kidney cancer (12.5); for transplant recipients, SMRs were highest for non-Hodgkin lymphoma (10.7), kidney cancer (7.8), and melanoma (5.8). Some 61.0% of patients on dialysis and 9.6% of transplant recipients who experienced cancer death had preexisting cancer. The SMRs for de novo cancer was 1.2 for patients on dialysis and 2.6 for transplant recipients. Conclusions: Patients on dialysis and transplant recipients experienced >2.5-fold increased risk of cancer death compared with the general population. This increased risk was largely driven by preexisting cancers in patients on dialysis and de novo cancers in patients with transplants.
Keywords: Cancer; nephrology
Rights: Copyright © 2019 by the American Society of Nephrology
DOI: 10.1681/ASN.2018090906
Grant ID: http://purl.org/au-research/grants/nhmrc/1092957
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.